Item Type: | Article |
---|---|
Title: | A coding mutation within the first exon of the human MD-2 gene results in decreased lipopolysaccharide-induced signaling |
Creators Name: | Hamann, L., Kumpf, O., Mueller, M., Visintin, A., Eckert, J., Schlag, P.M. and Schumann, R.R. |
Abstract: | MD-2 is an accessory protein of the Toll-like receptor (TLR)-4, necessary for assembling a receptor complex to sense low quantities of lipopolysaccharide in order to subsequently trigger innate immune responses. MD-2 and TLR-4 are expressed on a variety of immunocompetent cells. Mutations within the TLR-4 gene have been shown to attenuate immune responses against lipopolysaccharide in mice. In humans, a TLR-4 polymorphism has been associated with a higher risk for developing severe Gram-negative sepsis and with a lower risk for atherosclerosis. Since MD-2 is an essential part of the lipopolysaccharide receptor complex, we screened 20 patients that underwent surgical cancer therapy for novel MD-2 mutations by a single-strand conformation polymorphism technique. In one patient we found an A right arrow G substitution at position 103, resulting in an amino-acid exchange from Thr 35 to Ala. Reporter gene assays revealed that this mutation resulted in a reduced lipopolysaccharide-induced signaling. The patient displayed an uneventful postoperative course, with the exception of slightly decreased TNF-alpha levels after in vitro stimulation with LPS as compared to wt patients. Genotyping of a further 41 patients by a newly developed Lightcycler/FRET method failed to detect any additional polymorphism carriers, indicating that this is a rare mutation. |
Keywords: | MD-2, TLR-4, Inflammation, LPS, Polymorphism |
Source: | Genes and Immunity |
ISSN: | 1466-4879 |
Publisher: | Nature Publishing Group |
Volume: | 5 |
Number: | 4 |
Page Range: | 283-288 |
Date: | 1 June 2004 |
Official Publication: | https://doi.org/10.1038/sj.gene.6364068 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page